Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Psychol Med. 2020 Jul;50(10):1706-1715. doi: 10.1017/S0033291719001788. Epub 2019 Jul 22.
Causes of the comorbidity of substance misuse with anxiety-related and depressive disorders (anxiety/depression) remain poorly known. We estimated associations of substance misuse and anxiety/depression in the general population and tested them while accounting for genetic and shared environmental factors.
We studied individuals born in Sweden 1968-1997 (n = 2 996 398) with follow-up in nationwide register data for 1997-2013. To account for familial effects, stratified analyses were conducted within siblings and twin pairs. Substance misuse was defined as ICD-10 alcohol or drug use disorder or an alcohol/drug-related criminal conviction. Three dimensions of ICD-10 anxiety and depressive disorders and a substance misuse dimension were identified through exploratory factor analysis.
Substance misuse was associated with a 4.5-fold (95% CI 4.50-4.58) elevated risk of lifetime generalized anxiety/depression, 4.7-fold (95% CI 4.63-4.82) elevated risk of panic disorder and agora/social phobia, and 2.9-fold elevated risk of phobias/OCD (95% CI 2.82-3.02) as compared to those without substance misuse. The associations were attenuated in within-family analyses but we found elevated risks in monozygotic twin pairs discordant for substance misuse as well as significant non-shared environmental correlations. The association between anxiety/depression and substance misuse was mainly driven by generalized anxiety/depression, whereas other anxiety/depression dimensions had minor or no independent associations with substance misuse.
Substance misuse and anxiety/depression are associated at the population level, and these associations are partially explained by familial liabilities. Our findings indicate a common genetic etiology but are also compatible with a potential partially causal relationship between substance misuse and anxiety/depression.
物质滥用与焦虑相关和抑郁障碍(焦虑/抑郁)共病的原因仍知之甚少。我们估计了普通人群中物质滥用和焦虑/抑郁的相关性,并在考虑遗传和共同环境因素的情况下对其进行了测试。
我们研究了出生于 1968-1997 年的瑞典个体(n=2996398),并在 1997-2013 年期间进行了全国性登记数据的随访。为了考虑家庭效应,在兄弟姐妹和双胞胎对中进行了分层分析。物质滥用的定义为 ICD-10 酒精或药物使用障碍或与酒精/药物相关的刑事定罪。通过探索性因素分析确定了 ICD-10 焦虑和抑郁障碍的三个维度和一个物质滥用维度。
与没有物质滥用的个体相比,物质滥用与终生广泛性焦虑/抑郁的风险增加了 4.5 倍(95%置信区间 4.50-4.58),与惊恐障碍和广场/社交恐惧症的风险增加了 4.7 倍(95%置信区间 4.63-4.82),与恐惧症/OCD 的风险增加了 2.9 倍(95%置信区间 2.82-3.02)。在家庭内分析中,这种关联有所减弱,但我们发现物质滥用不一致的同卵双胞胎对中存在风险增加,并且存在显著的非共享环境相关性。焦虑/抑郁与物质滥用之间的关联主要由广泛性焦虑/抑郁驱动,而其他焦虑/抑郁维度与物质滥用几乎没有独立关联。
物质滥用和焦虑/抑郁在人群水平上相关,这些关联部分是由家族倾向解释的。我们的研究结果表明,它们具有共同的遗传病因,但也可能存在物质滥用和焦虑/抑郁之间潜在的部分因果关系。